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Systems Biology
Karthik Raman and Nagasuma Chandra
Systems biology seeks to study biological systems as a whole,
contrary to the reductionist approach that has dominated
biology. Such a view of biological systems emanating from
strong foundations of molecular level understanding of the
individual components in terms of their form, function and
interactions is promising to transform the level at which we
understand biology. Systems are defined and abstracted at
different levels, which are simulated and analysed using
different types of mathematical and computational tech-
niques. Insights obtained from systems level studies readily
lend to their use in several applications in biotechnology and
drug discovery, making it even more important to study
systems as a whole.
1. Introduction
Biological systems are enormously complex, organised across
several levels of hierarchy. At the core of this organisation is the
genome that contains information in a digital form to make
thousands of different molecules and drive various biological
processes. This genomic view of biology has been primarily
ushered in by the human genome project. The development of
sequencing and other high-throughput technologies that generate
vast amounts of biological data has fuelled the development of
newways of hypothesis-driven research.Development of compu-
tational techniques for analysis of the large data, aswell as for the
modelling and simulation of the complex biological systems have
followed as a logical consequence. Simulatable computational
models of biological systems and processes form the cornerstone
of the emerging science of systems biology.
Traditionally, biologyhas focusedon identifying individual genes,
proteins and cells, and studying their specific functions. Each of
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these is indeed extremely important in understanding the indi-
vidual molecules, but as individual isolated pieces of informa-
tion, they are insufficient to provide insights about complex
phenomena such as human health and disease. As an analogy, to
study an aircraft, focused detailed studies on individual compo-
nents such as the engine, wings and tail, would not be sufficient
to understand how an aircraft can fly. More importantly, it would
not provide any understanding of what component influences
what other component in what manner and to what extent, an
understanding which is very important to effectively set things
right when something malfunctions. In the same way, since
diseases occur when there is some malfunction in the form or
function of one or more of the cellular components, we need an
understanding how various molecules in a cell influence each
other in health, in order to attempt curing or correcting it to the
extent possible.
The scale at which various molecular level studies can now be
carried out is providing us systematic data on many fronts en-
abling us to reconstruct holistic models of larger systems [1].
Systems biology seeks to study biochemical and biological sys-
tems from a holistic perspective, promising to transform how
biology is done.The goal is for a comprehensive understanding of
the system’s influence on its individual components, leading to
the appearance of complex properties such as robustness, emer-
gence, adaptation, regulation and synchronisation, seen so very
often in biological systems. Essentially, systems biology advo-
cates a departure from the reductionist viewpoint, emphasising
on the importance of a holistic view of biological systems. It also
aims at a departure from the “spherical cow” 1, in trying to
encapsulate the enormous complexity of biological systems in
greater detail. Systems biology adopts an integrated approach to
study and understand the function of biological systems, particu-
larly, the response of such systems to perturbations such as the
inhibition of a reaction in a pathway, or the administration of a
drug. It can of course be argued that systems biology is just a new
name for the conventional disciplines such as physiology and
1A euphemism often directed at
the severe approximations that
characterise modelling.
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pharmacology, which are well established for several decades
now. Undoubtedly, these disciplines emphasise the need for con-
sidering whole systems. Yet, systems biology emerges as a new
discipline, since it differs from the conventional disciplines in a
fundamental way: the latter treat much of the whole system as a
‘black-box’, giving us only an idea of the end picture but not
enabling us to ask ‘why’ or ‘how’ a particular outcome is seen.
Systems biology on the other hand aims to reconstruct systems by
a bottom-up approach, with detailed knowledge about the indi-
vidual components thatmake up the systemand how these compo-
nents interact with each other. Modelling and simulation of com-
plex biological networks form the cornerstone of systems biology;
the coupling of in silico models with in vivo and in vitro experi-
mentation, with modelling guiding experimentation and experi-
mentation aiding in model refinement, can provide impetus to
improve the understanding of biological systems. Effects and
influences of one component on the other are deciphered, provid-
ing a greater understanding of how genotypes relate to pheno-
types.
2. Elements of Systems Biology
Systems biology, being a holistic approach involves modelling
and analysis of metabolic pathways, regulatory and signal trans-
duction networks for understanding cellular behaviour. There are
also various levels of abstraction at which these systems are
modelled, with a wide variety of techniques that can be employed
based on the quality and quantity of data available.
The critical step in the modelling and analysis of these pathways
is their reconstruction, involving the integrationof diverse sources
of data to create a representation of the chemical events underly-
ing biological networks [2]. A variety of high-throughput experi-
ments have been developed to provide extensive data on the
proteome, metabolome, transcriptome and the reactome in a cell
(see Box 1 for glossary of terms). Some of these techniques
include microarray analyses of the transcriptome and mass spec-
trometry analyses that generate proteomics data. It is important to
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understand that these experiments generate genome-scale ‘omics’
data, which cover a majority of the components such as metabo-
lites, transcripts and proteins, in a cell. Another major feature of
systems biology is the strong integration of experiment with
theory; it is quite common that a model is used to generate one or
Box 1. Glossary of Some Terms Used and their Related Concepts
Genomics and other ‘omics’: The German botanist Hans Winkler coined the term ‘genome’ in 1920 by
combining thewordsGENe and chromosOME.Aprecise definition of genome is ‘all theDNA in a cell’ because
this includes not only genes but also DNA that is not part of a gene, or non-coding DNA or in other words, all
the genetic material in the chromosomes of a particular organism’; its size is generally given as its total number
of base pairs. In the same way, a proteome is a collection of all proteins, coded by a genome. The human
proteome is the collection of proteins found in the human body. With the success of large-scale quantitative
biology projects such as genome sequencing, the suffix ‘-ome-’ has migrated to a host of other contexts: Omics
such as genomics, transcriptomics, proteomics,metabolomics or interactomics. The suffix ‘ome’ often signifies
totality of some sort.
Genome Sequence refers to the sequence of consecutive DNA ‘letters’ spanning all the chromosomes of a cell
from start to finish.
Gene Expression: This refers to the ‘turning on’ of a gene. Most human genes are active, or turned on, only
in certain cells under certain conditions. Genes for eye colour are active in eye cells but not in stomach cells.
Similarly, some genes may lie dormant for years and then turn on and become malignant late in life.
Transcription is the process of ‘turning on’, or activating a gene.
Genotype and Phenotype: Genotype refers to the particular form of a gene a person has. The genetic
constitution of an organism, as distinguished from its physical appearance (its phenotype). A phenotype on the
other hand is the physical trait such as red hair, or behaviour such as anxiety. A phenotype results from the
‘expression’ of a gene or genes.
Network: A network is generally a collection of related nodes, connected on the basis of interactions. It is
essentially a map of ‘who interacts with whom’. The most common kinds of networks are protein–protein
interaction networks, cataloguing how different proteins interact with one another within the cell.
Hub:Much like the hub of a wheel, highly connected nodes in networks are referred to as hubs. These often
are very important to network function and at the same time are the ‘Achilles heels’ of many real-world
networks. In the context of biological networks, hubs may present interesting drug targets.
Data-driven Modelling: Traditional physical modelling is knowledge-driven, where knowledge is derived
from first principles; for example, the modelling of the motion of a pendulum based on ODEs from physical
laws. Data-driven modelling, in contrast, is employed when certain input–output characteristics of the system
are known but there is only limited knowledge on the system in question. Linear regression is a very simple
example of a data-driven model.
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more hypotheses, which are then tested experimentally, and
iteratively contribute tomodel refinement. In essence, the various
parts of a systems biology study are (a) define amodel system, (b)
identify a choice of attributes/parameters to study the system that
is appropriate for the problem being addressed, (c) comprehen-
sive experimental measurements, (d) appropriate mathematical
abstraction of the system that is computationally tractable and (e)
computational simulations that can generate and test various
hypotheses, (f) that can later be verified by experimental ap-
proaches (Figure 1).
2.1 System Definition
Systems biology experiments are often characterised by a syn-
ergy between theory and experiment (Figure 1). As in traditional
biological experiments, the chosen model system must be suit-
able for experimental investigations, and should also be complex
enough to capture the biological phenomenon of interest. Simple
bacteria such as E. coli are often used as model organisms to
understand the organisation and behaviour of prokaryotic sys-
tems. Saccharomyces cerevisiae is the de facto standard model
organism for understanding eukaryotic systems. Similarly, the
fruitfly Drosophila and the worm Caenorhabditis elegans are
Figure 1. Systems biology
process. This process re-
lies on an iterative proce-
dure of model building, ex-
perimental verification,
model analysis and model
refinement. The concepts
that underlie these pro-
cesses have been shown
as clouds.
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used as models to incrementally understand more and more com-
plexmulti-cellular organisms. It is important to note that, although
some of these systems are significantly less complex than mam-
malian systems, several processes are conserved, leading to the
possibility of very useful predictions of the behaviour of mamma-
lian systems from themodelling of simpler systems. Very often, it
is impractical to consider whole organisms or whole cells, espe-
cially to address questions pertaining to the mechanism of a given
process. Pathways or sets of pathways function as modules of the
larger systems, which provide a practical framework to study the
biological processes/phenomena.
Metabolic pathways, signal transduction pathways and regulatory
pathways have been studied from a variety of organisms from
which a wide range of biological insights have been obtained.
Such pathways have also been combined into the larger context of
networks, where the abstraction is often a bit less quantitative,
again for practical reasons. Studies on transcriptional network of
yeast,metabolic networkofE. coli, serve as examples of studies at
this level. Thus, the scale of the system can vary from tens of
components to several thousands. The resolution of information
can also vary fromdetailed atomistic information to broad cellular
views. For example, a defined model could contain thermody-
namic data of the metabolic reactions in a given pathway, that in
turn have sound correlationswith the three-dimensional structures
of the involved enzymes. On the other hand the defined system
could simply contain logical connections between different cellu-
lar states implying functional correlations without any further
details on the cells themselves. A systems biology approach is
characterised by a series of iterative experimentation and model
refinement (also see Figure 1), often using perturbations to the
system as a handle to affirm roles of known components as well as
to discriminate between alternative models [3]. Another impor-
tant feature is that most of these components, fromcomputation to
high-throughput laboratory experiments are amenable to automa-
tion.
Pathways or sets of
pathways function as
modules of the larger
systems, which
provide a practical
framework to study
the biological
processes/
phenomena.
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2.2Modelling in Systems Biology: Model Abstraction
Models are created to simulate a process or a set of processes
observed in the natural world in order to gain insights into process
mechanisms and predict outcomes for a given set of specific input
parameters. Conceptual and theoretical modelling constructs are
expressed as sets of algorithms and implemented as software
packages. What constitutes a model depends upon what is under-
stood about a given process and how best it is computationally
tractable. For example, in drug discovery, amodel can refer to the
relationship of the structure of a target molecule to its ability to
bind a certain type of ligand at one end of the spectrum, while at
the other end, it can refer to a statistically derived relationship of
a set of ligands to a particular biological activity, with no explicit
consideration of the mechanism or the basis of such activities.
Conceptual modelling is an integral part of problem solving in
general and in fact an essential component of any activity that
attempts to achieve a goal in a systematic way.
The advantages of having a model are manifold: (a) it gives the
precise definition of the components of a given system (or the
genotype), (b) it allows performing simulations and monitoring
the end-effect, whichmay be the given phenotype in this context,
(c) it helps in dissecting the role of every component in the system
through the analysis of perturbations, (d) it helps us to interpret
complex hard-to-understand problems, (e) it helps in studying
systems that are impractical to study through conventional ex-
periments, (f) it helps both in designingminimal systems that can
result in a particular phenotype, as well as analysing the effect of
the addition of newer components into the framework, and (g) it
is highly amenable for high-throughput simulations and highly
cost-effective, useful especially in applications such as drug
discovery.
Thus, models not only provide significant insights into the under-
lying biology and application opportunities, but also enable the
efficient study of what may be highly impractical, or even impos-
sible through biochemical andmolecular biology experiments. It
Models are created to
simulate a process or
a set of processes
observed in the
natural world in order
to gain insights into
process mechanisms
and predict outcomes
for a given set of
specific input
parameters.
What constitutes a
model depends
upon what is
understood about
a given process
and how best it is
computationally
tractable.
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must however be emphasised that a model is only as good as our
understanding of what constitutes a system and how it has been
built.Model building is thus a critical step in in silico analysis and
is often iterated and refined with validation steps.
Given that biological systems and processes are understood at
many different levels and in many different aspects, it is no
wonder that many different kinds of models should exist in
practice. Figure 2 illustrates that models span a wide range,
emanating from the organisational hierarchy in which biological
systems are understood.
On one hand, there are structural models at atomic levels imply-
ing certain functions, whereas on the other hand, there are whole
genome-based mathematical models of either pathways or entire
organisms implying functions at very different levels. It is
Figure 2. Modelling tech-
niques in systems biology.
The various methods have
been represented along-
side an axis that details the
granularity (or resolution)
typical for each method.
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important to understand the abstraction levels of the models, so
that conclusions are drawn at appropriate levels from the analy-
ses. The choice of the method depends upon the type and extent
of data available, as well as the objective of the modelling
exercise in terms of the level at which the system is desired to be
understood.
Models are routinely built from a variety of sources, which vary
in the degree of accuracy of experiments recorded and often
depend even on the interpretation of data available.Model valida-
tion is a critical quality control step that endorses the results
obtained through simulation of the model. Typical model valida-
tion involves the comparison of model predictions against known
biochemical and genetic evidences obtained by various experi-
ments, particularly when experimental data has not been used for
tuning the models.
3. Key Properties of Biological Systems/Models
Biological systems are characterised by several key properties,
which distinguish them frommodels in other disciplines. Knowl-
edge of these fundamental principles, which characterise biologi-
cal systems, is important both for understanding their function
and for modelling them. Some of these interesting properties are
discussed below.
3.1 Irreducibility
Irreducibility is an important concept that makes systems think-
ing important. We may undoubtedly gain significant insight into
each of the components of the system by studying them individu-
ally, but we will require to study the system as a whole in order to
gain a holistic perspective of what these components do when
they are all put together in an appropriate manner. An analogy to
a book is often drawn, where one cannot understand a book by
reading one word at a time. In other words, knowing the meaning
of every word in a book does not tell us what the book is about.
They have to be placed in context to grasp the story in the book.
It is this context that is sought out in systems biology; thus it is not
Models are routinely
built from a variety of
sources, which vary
in the degree of
accuracy of
experiments
recorded and often
depend even on the
interpretation of data
available.
The larger properties
that arise out of that
context are often
referred to as
‘emergent
properties’. Emergent
properties are thus
consequences of the
interactions between
system components.
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only the form and function of individual molecules, but rather
their functional orchestration in a ‘context’ in a complex manner
that makes a living species. The larger properties that arise out of
that context are often referred to as ‘emergent properties’. Emer-
gent properties are thus consequences of the interactions between
system components.
3.2 Emergence
Systems are composed of individual elements or ‘parts’ that
interact in various ways. In general, the behaviour of a system is
quite different frommerely the sumof the functions of its various
parts. As Anderson put it as early as 1972, in his classic paper by
the same title, “More is different” [4] , it is not possible to reliably
predict the behaviour of a complex system, despite a good knowl-
edge of the fundamental laws governing the individual compo-
nents:
The ability to reduce everything to simple fundamental laws does
not imply the ability to start from those laws and reconstruct the
universe. The constructionist hypothesis breaks down when con-
fronted with the twin difficulties of scale and complexity. At each
level of complexity entirely new properties appear. Psychology is
not applied biology, nor is biology applied chemistry. We can
now see that the whole becomes not merely more, but very
different from the sum of its parts.
PWAnderson, 1972 [5]
This reinforces the need to develop methods to study biological
systems at the systems level, rather than at the level of individual
components.
3.3 Complexity
The term complexity, a concept linked to the concept of systems
itself, is often used in a variety of disciplines to characterise a
system with a number of components intricately linked to each
other, giving rise to behaviours that may not be described by
In general, the
behaviour of a
system is quite
different from
merely the sum of
the functions of its
various parts.
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simple models. Emergent behaviour (described above) is one of
the most fundamental features of complex systems. Health or
disease are examples of complex systems. These cannot be
predicted simply by analyzing the individual ligands or proteins
that comprise the cells. A more complete picture of their context
would be necessary to achieve it. Biological systems, needless to
say, are extraordinarily complex, which is evident in individual
prokaryotic cells, let alonemulti-cellular organisms. For example
an E. coli cell has about 4500 genes coding for at least as many
proteins. At the outset, trying to understand how these many
proteins embedded in less than femtolitre (10–15 L) of volume,
perform together to enable the many functions of the E. coli cell
appears to be a daunting task. However, we can understandmany
aspects of the cell if we divide complexity in hierarchies and then
focus on understanding each individual level in a stepwise man-
ner and then re-assimilate them in an appropriate context. In other
words, understanding how, at the bottom of the hierarchy, DNA,
proteins and metabolites function in individual cells, helps us to
understand how different proteins give rise to pathways, how
pathways come together to form processes, and how these are
organised in a functional cell (Figure 3). In higher organisms, we
Figure 3. Levels of hierar-
chies for understanding
and modelling biological
systems. The figure illus-
trates different types of
models that are appropri-
ate at a given level of hier-
archy.Theinformation they
encode (abstraction level)
are listed for each of them
as also the methods that
are in current practice to
design, build and analyse
the models.
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would extend this to understanding how different cell types are
formed and organised in tissues, how tissues make complex
organs, and finally, howmanydifferent organs are orchestrated in
the top hierarchical level, the organism. However, amidst this
complexity, there is modularity with many commonmechanisms
for a range of biological events. Different cell types and functions
use recurrent basic mechanisms of organisation and communica-
tion; thus common patterns underlie diverse expressions of life.
Understanding single cell types, even when the organisms con-
taining them are evolutionarily distant, such as bacteria and
humans, would inevitably provide enormous amount of informa-
tion to understand other cell types. Complexity has important
implications for modelling; the complexity of large systems often
makes them intractable for analyses. Therefore, large systems are
often broken down into their constituent modules, or sub-sys-
tems, which are more amenable for analyses.
3.4 Modularity
Bacterial systems may be viewed as comprising modules, which
maybe insulated or decoupled from one another, or alternatively,
connected to one another. Modules constitute semi-autonomous
entities with dense internal functional connections and relatively
looser external connections with their environment. Modularity
or the encapsulation of functions, can contribute to both robust-
ness (by confinement of damage) and to evolvability (by rewiring
of modules for new functionality) [5]. An obvious example of a
module is a cell in a multi-cellular organism, which interacts with
both the environment and other cells. Modules are also com-
monly organised in a hierarchical fashion: a cell is composed of
organelles, while also being a part of higher structures such as
tissues and organs (Figure 3) . At a different level, a signal
transduction systemis an extendedmodule that achieves isolation
on account of the specificity of the binding of chemical signals to
receptor proteins as well as the specificity of the interactions
between the signalling proteins within the cell [5].
Bacterial systems
may be viewed as
comprising
modules, which
may be insulated
or decoupled from
one another, or
alternatively,
connected to one
another.
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3.5 Robustness and Fragility
Robustness may be understood as the relative property of a
system to retain stability despite several perturbations, internal or
external. No system can be robust to all kinds of perturbations.
Robustness in biological systems is achieved using several com-
plexmechanisms involving feedback, alternative (fail-safe)mecha-
nisms featuring redundancy and diversity (heterogeneity), struc-
turingof complex systems into semi-autonomous functional units
(modularity), and their reliable co-ordination via establishment
of hierarchies and protocols. Sensitivity or fragility, however,
characterises the ability of organisms to respond adequately to a
stimulus. Robustness and fragility have been described in the
literature as inseparable; the ‘robust, yet fragile’ nature of com-
plex systems is thought to exhibit ‘highly optimised tolerance’.
Complex engineered systems (and biological systems) are often
quite resistant to designed-for uncertainties, but quite susceptible
to other perturbations. For example,modern aeroplanes, vis-à-vis
the Wright brothers’ aeroplane, are quite stable to atmospheric
perturbations, but are fundamentally sensitive to complete elec-
trical failure, due to the tight dependence of the control on a wide
variety of electrical systems. Several biological systems are quite
sensitive to what may be quantitatively small perturbations.
There are several examples of networks which exhibit high
insensitivity to attacks on nodes in random, but high sensitivity
showing high disruption when there is a targeted attack on a few
highly connected (hub) nodes.
4. Practice of Systems Biology
Systems biology primarily involves the building of models of
systems, detailing metabolism, regulation, signalling and pro-
tein–protein interactions (Figure 4). A variety of modelling tech-
niques encompassing awide spectrumof resolution and accuracy
are used. Figure 2 shows some of these methods, also indicating
the level of detail that the method usually deals with. The levels
of biological organisational hierarchy at which suchmethods can
Systems biology
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Robustness may
be understood as
the relative
property of a
system to retain
stability despite
several
perturbations.
144 RESONANCE  February 2010
GENERAL  ARTICLE
Figure 4. An overview of modelling in systems biology. This figure illustrates the various compo-
nents of the systems biology modelling cycle, of how various types of experimental data are
translated to a mathematical model, followed by simulation. The simulation results are then used
to infer predictions (system behaviour), which are often compared against experimental results,
leading to further improvements/enhancements to the mathematical model.
be used have already been illustrated in Figure 3. Some of the
tools and resources useful for systems level modelling and simu-
lation of biological systems are listed in Table 1.
At the highest level of resolution, there are atomistic models,
followed by molecular recognition models, incorporating details
at the lowest atomic level. These are followed by mechanistic
models of molecular networks, which are usually realised using
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Models for Simulation
Biomodels.net http://www.biomodels.org/
CellML http://www.cellml.org/
Panther http://www.pantherdb.org/
Pathway Databases
BioCyc http://biocyc.org/
BioChemWeb http://www.biochemweb.org/
KEGG Pathway http://www.genome.jp/
Reactome http://www.reactome.org/
Quantitative Data
BioPAX http://www.biopax.org/
BRENDA http://www.brenda-enzymes.info/
Systems Biology Standards
LibSBML (API) http://sbml.org/
MathML http://sbml.org/
SBML http://sbml.org/
little b http://www.littleb.org/
MIRIAM http://www.biomodels.org/
Pathway Design and Network Based Tools
Cell Designer http://www.celldesigner.org/
Cytoscape http://cytoscape.org/
JDesigner http://www.sys-bio.org/software/jdesigner.htm
Metatool http://www.biocyc.org/
SBGN http://www.sbgn.org/Main_Page
Teranode http://www.teranode.com/
GUI-Modelling and Simulation Tools
E-Cell http://www.e-cell.org/
Gepasi http://www.gepasi.org/
MATLAB http://www.mathworks.com/
Maple http://www.maplesoft.com/
SBML Toolbox http://sbml.org/
Systems Biology Workbench (SBW) http://sbml.org/
Non-GUI Modelling and Simulation Tools
Pathway Analyzer http://sourceforge.net/projects/pathwayanalyser
COBRA http://gcrg.ucsd.edu/
JigCell http://jigcell.biol.vt.edu/
Table 1. This table outlines some of the important resources for systems biology, from pathway
databases, to databases of kinetic parameters, as well as modelling and simulation tools.
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differential equations detailing kinetic parameters and stochastic
modelling, to account for inherent noise in biochemical systems.
At a lower level of resolution are the constraint-based modelling
techniques such as flux balance analysis (FBA) and stoichiomet-
ric analyses, which rely more on global properties of networks,
such as stoichiometry and mass conservation, rather than the
intricate kinetic parameters.
Boolean networks thrive with lesser data, where interactions
between network components are represented bymeans of Bool-
ean functions such as ‘OR’, ‘AND’, ‘ANDNOT’ and so on. Such
discrete modelling techniques have applications in several areas.
Topological analyses of networks, which are constructed pre-
dominantly based on knowledge of association or causality, can
also provide interesting insights into the organisation and proper-
ties of biological systems. At a further lower level of resolution
are Bayesian networks and other statistical learning models, as
well as qualitative models of biological systems.
The choice of methods for modelling and simulation is predomi-
nantly determined by the quality and quantity of data that are
available, as well as the desired objective of the modelling
exercise. When well-characterised kinetic parameters are avail-
able for a set of reactions in a given pathway, a kinetic model
consisting of differential equations describing the rate of change
of concentration of each of the metabolites can be constructed.
Such a system of equations can then be solved to obtain insights
about the essentiality of each component. For example, a math-
ematical model of glycolysis in T. brucei has been built, based on
in vitro enzyme kinetic data [6].
When kinetic parameters are not available, constraint-basedmod-
els of reaction networks can be constructed and analysed, obtain-
ing insights into the metabolic capabilities of systems as well as
gene essentiality [2, 5]. At a lower level of resolution, interaction
networks of metabolites or more importantly, proteins, can be
constructed and analysed, obtaining fundamental insights into
centrality, and consequently lethality (or essentiality) [7].
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4.1 Kinetic Modelling
When sufficient mechanistic details are available for cellular
processes such asmetabolism, signal processing and gene regula-
tion, detailed quantitative predictions about cellular dynamics
can be made. Typically, ordinary differential equations (ODEs)
are used for this purpose. ODE-based simulations involve a
mechanistic representation of the reaction network, with all the
involved association/dissociation constants, rate constants and
affinities or appropriate approximations. Since such data is not
always available, thismethodhas limited applicability.Biochemi-
cal reactions are regularly represented by differential equations
that indicate the rate of consumption and production of various
species involved in the reactions. The systemof differential equa-
tions so generated can be solved and the system can be simulated.
An important caveat is that even where kinetic parameters are
available, they have often been determined in vitro, rather than in
vivo, which again significantly impacts the accuracy of simula-
tions. Genome-scale kineticmodellingof biological systems is an
interesting challenge that lies ahead in systems biology.
4.2 Constraint-Based Modelling
Kinetic data available for the simulation of networks are quite
scarce, rendering the kinetic modelling of metabolic networks a
challenging task. An approach used often to overcome the limita-
tion of data, is to add appropriate ‘constraints’ on the systems, so
as to make it feasible to find meaningful solutions. Constraints
are generally in the form of rules, which define the upper and
lower limits of the acceptable values for a given variable or in the
form of some well-known laws of chemistry that must be upheld
while solving for the system. Constraint-based analyses of recon-
structed metabolic networks have proved to be quite effective in
various applications such asmetabolic engineering, prediction of
outcomes of gene deletions, and in the elucidation of cellular
regulatory networks .
One specific example of metabolic modelling using a constraint-
When sufficient
mechanistic details
are available for
cellular processes
such as metabolism,
signal processing and
gene regulation,
detailed quantitative
predictions about
cellular dynamics can
be made.
Genome-scale kinetic
modelling of biological
systems is an
interesting challenge
that lies ahead in
systems biology.
148 RESONANCE  February 2010
GENERAL  ARTICLE
based approach is Flux-Balance Analysis (FBA) [8], which uses
linear optimisation to determine the steady-state reaction flux
distribution in a metabolic network by maximising an objective
function, such as ATP production or growth rate. FBA involves
carrying out a steady state analysis, using the stoichiometric
matrix for the system in question.An important assumption is that
the cell performs optimally with respect to a metabolic function,
such as maximisation of biomass production or minimisation of
nutrient utilisation, on the premise that selection pressures during
evolution, guide systems towards optimality. Once an objective
function is fixed, the system of equations can be solved to obtain
a steady state flux distribution. This flux distribution is then used
to interpret the metabolic capabilities of the system.
FBA has the capabilities to address the effects of gene deletions
and other types of perturbations on the system. Gene deletion
studies can be performed by constraining the reaction flux(es)
corresponding to the gene(s) (and therefore, of their correspond-
ing proteins(s)), to zero. Effects of inhibitors of particular pro-
teins can also be studied in a similar way, by constraining the
upper bounds of their fluxes to any defined fraction of the normal
flux, corresponding to the extents of inhibition. FBA gives a
general idea of the metabolic capabilities of an organism; gene
deletion studies using FBA yield information on the criticality of
genes for the growth/survival of an organism. The analysis of
perturbations using flux balance models of metabolic networks
provides a handle to analyse the lethality of individual gene
deletions, as well as double knock-outs, to identify pairs of genes
that are indispensable, as well as to determine and analyse syn-
thetic genetic interactions.
4.3 Pathway Models
A pathway model is the lowest level of abstraction in system-
based models. It looks at only the reactions in the metabolome of
an organism and accounts for several of the interactions between
the gene products of an organism and its metabolites. However,
this is a significant improvement on the mere sequence data that
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is often employed for modelling and analysis. Several paradigms
exist for pathway modelling and they are reviewed in the litera-
ture [9] . Basedon the availability of data, a suitable paradigmcan
be chosen for modelling; this affects the accuracy of the simula-
tions performed on the systems. Some examples of the use of
pathway models are illustrated in later sections.
4.4 Network-Based analysis
Barabási and Oltvai [10] have shown that tools from network
theory may be adapted to biology, providing profound insights
into cellular organisation and evolution. Hubs which are heavily
connected components in a graph may be identified and targeted
to ‘knock out’ a system. In a typical interaction-based modelling
of metabolic pathways, connections between the various proteins
andmetabolites in a system are obtained.When further analysed,
specific hubs emerge to be more connected. These hubs may
serve as interesting targets as they have the potential to affect
several other connections in the system. The advantage of inter-
action-based modelling is that the amount of data required is
relatively less and it is possible to generate interaction networks
from existing databases. There is a need for more such derived
databases, whichwould be of immense use in applications such as
drug discovery.
5. Promise of Systems Biology
Systems biology finds application in several fields, including
metabolic engineering and drug discovery. It has an immense
potential to improve our fundamental understanding of biological
systems. Biologyhas itself immensely benefited frombuilding on
the study of ‘model’ organisms such as Arabidopsis thaliana,
Drosophila melanogaster, C. elegans and Escherichia coli. Sys-
tems approaches have been successfully applied for the study of
model organisms such as Escherichia coli, where the metabolic
capabilities have been predicted in silico and verified experimen-
tally. Systems-level studies of organisms such as S. cerevisiae are
expected to significantly impact the study of more complex
organisms such as humans.
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An excellent application of systems biology in metabolic engi-
neering, with commercial potential, has been illustrated by
Stephanopoulos and co-workers, for improving lysine produc-
tion. Stephanopoulos and co-workers have also reported a ge-
nome-wide FBA of Escherichia coli to discover putative genes
impacting network properties and cellular phenotype, for re-
engineering lycopene synthesis [11]. Metabolic fluxes were cal-
culated such as to optimise growth, followed by scanning the
genome for single and multiple gene knockouts that yield im-
provedproduct yieldwhilemaintaining acceptable overall growth
rate. For lycopene biosynthesis in Escherichia coli, such targets
were identified and subsequently tested experimentally by con-
structing the corresponding single, double and triple gene knock-
outs. A triple knockout construct (gdhAaceAfdhF) was iden-
tified, which exhibited a 37% increase over an engineered, high
producing parental strain.
Another field where excellent progress has been made is in the
modelling of the heart as a virtual organ, at various levels [12].
Models of different cell types in the heart have led to the creation
of the first virtual organ, which is being used in drug discovery
and testing and in simulating the action of devices such as cardiac
defibrillators. The culmination of systems modelling lies in the
modelling of complete systems, accounting for all component
reactions, the localisation of these components and their interac-
tions. The interaction between these organelles or compartments
and the interface with the physical world, in terms of external
temperature, pH and other effects becomes more relevant in
highest levels of biological hierarchy (Figure 3). Computational
models of human physiology come into play both to relate to
whole animal models used in traditional pharmacology andmore
importantly, to build integrated data-driven models that can be
refined to mimic the human physiology more closely.
The IUPS Physiome project (http://www.physiome.org.nz/) is a
project that is aimed at describing the human organism quantita-
tively, to understand key elements of physiology and pathophysi-
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ology. The salient features of the project are the databasing of
physiological, pharmacological and pathological information on
humans and other organisms and integration through computa-
tional modelling. The models span a wide range, from diagram-
matic schema suggesting relationships among system compo-
nents, to fully quantitative computational models describing the
behaviour of physiological systems and response of an organism
to environmental change. Each mathematical model is an inter-
nally self-consistent summaryofavailable information and thereby
defines a working hypothesis about how a system operates.
Predictions from such models are subject to tests, with new
results leading to new models. The goal is to understand the
behaviour of complex biological systems through a step-by-step
process of building upon and refining existing knowledge.
Efforts are underway to extend these concepts further to virtual
patients. Entelos’ PhysioLab (http://www.entelos.com/) has de-
veloped models of human physiology that supplement animal
model systems. For example, Entelos’ Diabetes PhysioLab has
more than 60 virtual patients, each one representing a hypothesis
of the pathophysiology of diabetes, constrained by the pathway
networks and consistent with validation experiments. Such mod-
els have the potential for performingpatient profiling, classifying
patient types and even to tailor-design treatment regimes, with a
long-term goal of making personalised medicine, a reality.
The possibility of drug discovery based on systems biology is
exciting – it holds promise for the discovery of more efficacious
drugs with fewer adverse effects. Often, adverse drug reactions
might emerge on account of the binding of the drug to proteins
other than the intended targets. By considering larger systems and
accounting for such possibilities, it is possible that such problems
may be identified by in silico analyses. It is envisaged that the
complete understanding of a system in terms of all the compo-
nents present and their complex interaction network would assist
in discovering the ideal drug, which has high specificity and
effectiveness.
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6. Future Perspectives
The enormous progress in the development of new methods in
different branches of biology and their abstraction through com-
putational models that we are currently witnessing, has already
shown enormous potential, both for understanding biological
processes at a better level, as well as for any application opportu-
nities. These opportunities, which are expected to increase even
more in the coming years, promise to make the mission of
creating data-driven models and simulations a reality, leading to
fundamental changes in the way we discover drugs. The predic-
tive power provided by data-driven computation has long been a
critical component in product development and safety testing in
other industries, from aerospace engineering to circuit design.
With the current rate of advances in systems biology, we can also
expect significant enhancements in pathway models, process
models and indeed in entire system models, both in terms of
mathematically representing complex phenomena as well as in
terms of mimicking and simulating the biological events. The
success of the virtual heart project [12] and creation of virtual
patients representing different pathophysiologies are suggestive
of this trend. We can also envisage that the use of
pharmacogenomics and tailor-made medicines could be distinct
possibilities in the near future. In short, the stage is all set for the
integration and application of skills from mathematics and com-
puter science to address complex problems in biology and medi-
cine, in a big way.
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